Is there a relationship between peripheral neuropathy and primary biliary cholangitis (PBC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Relationship Between Neuropathy and Primary Biliary Cholangitis

Yes, there is a well-established relationship between peripheral neuropathy and primary biliary cholangitis (PBC), with both peripheral and autonomic neuropathy occurring commonly in PBC patients, though these neurological complications are rarely clinically disabling.

Prevalence and Clinical Significance

Peripheral neuropathy is surprisingly common in PBC, affecting approximately 40% of patients, though symptoms are rarely volunteered spontaneously and must be specifically sought during clinical evaluation 1. The neuropathy manifests with both symptoms and signs plus peripheral neurophysiological abnormalities 1.

  • Autonomic neuropathy is even more prevalent, occurring in approximately 63% of PBC patients, with predominantly parasympathetic abnormalities 1
  • The autonomic impairment may be of prognostic significance despite rarely being clinically disabling 1
  • Neuromuscular manifestations including both myopathies and neuropathies have been documented, with demyelinating neuropathy reported in case series 2

Pathophysiologic Relationship

A close association exists between autonomic and peripheral nerve dysfunction in PBC, suggesting a generalized neuropathy affecting multiple components of the nervous system 1.

  • Heart rate variation on deep breathing correlates significantly with peroneal nerve conduction velocity (r = 0.67, P < 0.001) and sural nerve conduction velocity (r = 0.52, P < 0.008) 1
  • Both autonomic and peripheral nerve function correlate with markers of hepatic damage, specifically serum bilirubin and albumin levels 1
  • The neuropathy appears related to hepatic damage itself rather than vitamin E deficiency or hyperlipidemia 1
  • The co-occurrence of PBC and neurologic diseases suggests a possible common pathogenic mechanism, though the exact etiopathogenesis remains unknown 2

Clinical Implications

Clinicians should actively screen for neuropathic symptoms in PBC patients rather than waiting for spontaneous reporting, as patients frequently do not volunteer these symptoms 1.

  • The neuropathy is typically not clinically disabling but warrants recognition 1
  • Autonomic dysfunction may have prognostic implications beyond its symptomatic impact 1
  • The severity of neuropathy correlates with disease severity markers (bilirubin, albumin), suggesting it may serve as an additional indicator of disease progression 1

Important caveat: While the 2018 British Society of Gastroenterology/UK-PBC guidelines 3 comprehensively address PBC management, they do not specifically discuss neuropathy as a complication or symptom requiring routine assessment, despite the research evidence demonstrating its frequency. This represents a gap between research findings and guideline recommendations that clinicians should be aware of when providing comprehensive PBC care.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.